Arterial wave reflections and determinants of endothelial function a hypothesis based on peripheral mode of action.

BACKGROUND Pulse waveform analysis (PWA) for determination of augmentation index (AIx), a measure of arterial wave reflections, has been used to assess endothelial function, but only in combination with provocative pharmacologic testing. We hypothesized that AIx under basal conditions would be related to endothelial function as well. METHODS We quantified arterial wave reflections as aortic AIx, using applanation tonometry of the radial artery, and PWA in 424 patients (mean age 64.6 years) undergoing coronary angiography. Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of endothelial nitric oxide (NO) synthase, were determined with a validated ELISA assay. In a group of the patients (n = 160), pulse wave velocity (PWV) was measured invasively during catheter pullback. Statistics were Spearman's correlation coefficient and multiple linear regression models. RESULTS We observed a positive, statistically significant correlation between AIx and ADMA (R = 0.11, P = .03), that was closer in 134 patients up to 60 years of age (R = 0.28, P = .001). In the latter group, the correlation was independent of age, gender, smoking, lipids, heart rate, diastolic blood pressure (BP), the presence of hypertension or diabetes, and the extent of coronary artery disease. In contrast, we observed a significant (R = 0.19, P = .02) correlation between PWV and ADMA that disappeared after correction for age and BP. CONCLUSIONS Our cross-sectional data indicate that ADMA levels are associated with increased arterial wave reflections, most likely due to decreased NO activity in small arteries and arterioles. This relationship is more pronounced in patients up to 60 years of age.

[1]  G. Sesti,et al.  Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. , 2003, Journal of the American College of Cardiology.

[2]  P. Vallance Importance of asymmetrical dimethylarginine in cardiovascular risk , 2001, The Lancet.

[3]  M. O'Rourke Ascending aortic pressure wave indices and cardiovascular disease. , 2004, American journal of hypertension.

[4]  M. Wolzt,et al.  Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus , 2005, Wiener klinische Wochenschrift.

[5]  J. Cockcroft,et al.  Basal NO Locally Modulates Human Iliac Artery Function In Vivo , 2005, Hypertension.

[6]  JamesLeiper,et al.  Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase , 2003 .

[7]  Azra Mahmud,et al.  Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension , 2005, Hypertension.

[8]  P. Tsao,et al.  Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.

[9]  Yasmin,et al.  Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). , 2005, Journal of the American College of Cardiology.

[10]  Ahmad Qasem,et al.  Endothelin-1 regulates arterial pulse wave velocity in vivo. , 2003, Journal of the American College of Cardiology.

[11]  P. Tsao,et al.  Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine , 2001, Circulation.

[12]  W. Nichols McDonald's Blood Flow in Arteries , 1996 .

[13]  D. Webb,et al.  Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. , 2002, Journal of the American College of Cardiology.

[14]  Thomas Weber,et al.  Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery Disease , 2004, Circulation.

[15]  Karsten Sydow,et al.  Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay , 2004, Clinical chemistry and laboratory medicine.

[16]  H. Struijker‐Boudier,et al.  Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.

[17]  T. Meinertz,et al.  Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. , 2005, European heart journal.

[18]  David J. Webb,et al.  Pulse‐Wave Analysis: Clinical Evaluation of a Noninvasive, Widely Applicable Method for Assessing Endothelial Function , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[19]  L. Brush,et al.  McDonaldʼs Blood Flow in Arteries , 1991 .

[20]  G. Watts,et al.  Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia , 1992, The Lancet.

[21]  P. Chowienczyk,et al.  Effects of Inhibition of Basal Nitric Oxide Synthesis on Carotid-Femoral Pulse Wave Velocity and Augmentation Index in Humans , 2003, Hypertension.

[22]  J. Feely,et al.  Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects , 2006, Journal of Human Hypertension.

[23]  Mark A. Creager,et al.  Endothelium-Derived Nitric Oxide Regulates Arterial Elasticity in Human Arteries In Vivo , 2001, Hypertension.

[24]  P. Fitzgerald,et al.  Contribution of endothelium-derived nitric oxide to coronary arterial distensibility: an in vivo two-dimensional intravascular ultrasound study. , 1995, American heart journal.

[25]  Christopher T. Chan,et al.  Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. , 2004, Journal of the American Society of Nephrology : JASN.

[26]  M E Safar,et al.  Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient: A Comparison With Atenolol , 2001, Hypertension.

[27]  R. Böger Association of Asymmetric Dimethylarginine and Endothelial Dysfunction , 2003, Clinical chemistry and laboratory medicine.

[28]  L. Lerman,et al.  Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. , 2006, European heart journal.

[29]  Shing‐Jong Lin,et al.  Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. , 2003, European heart journal.

[30]  D. Webb,et al.  Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. , 2002, British journal of clinical pharmacology.

[31]  Thomas Weber,et al.  Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. , 2005, European heart journal.